Chinese Collateralization in Comparative Perspective: ‘Belt and Suspenders’ on the Belt and Road
Journal of International Development · 2026-08 · 38 (6) · 976-988
DOI: 10.1002/jid.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Development, online erschienen am 02.07.2026. Verfasst von Deborah Brautigam und 1 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben. Gefördert von: Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
How do Chinese banks secure their loans to governments and public enterprises in the Global South? How do Chinese practices compare with those of other commercial and official creditors? We find that Chinese creditors rarely secure their overseas loans with real property, but primarily utilize liquid assets in escrow accounts that operate as payment mechanisms. Chinese practices represent a hybrid ‘belt and suspenders’ approach to lending to countries where neither the belt (government) nor the suspenders (collateral) are considered fully reliable. Our review suggests strong historical parallels between Chinese official and commercial creditors and analogous lenders in Japan and the West, bringing into question the uniqueness of China as a creditor.
Förderung
- Bill and Melinda Gates Foundation
Zitieren
APA
Brautigam, D., & Huang, Y. (2026). Chinese Collateralization in Comparative Perspective: ‘Belt and Suspenders’ on the Belt and Road. Journal of International Development, 38(6), 976-988. https://doi.org/10.1002/jid.70098
Vancouver
Brautigam D, Huang Y. Chinese Collateralization in Comparative Perspective: ‘Belt and Suspenders’ on the Belt and Road. Journal of International Development. 2026;38(6):976-988. doi:10.1002/jid.70098
BibTeX
@article{Brautigam2026,
author = {Brautigam, Deborah and Huang, Yufan},
title = {Chinese Collateralization in Comparative Perspective: ‘Belt and Suspenders’ on the Belt and Road},
journal = {Journal of International Development},
year = {2026},
volume = {38},
number = {6},
pages = {976--988},
doi = {10.1002/jid.70098}
}
EUVIMED